Cyclin D1 and vitamin D signaling in oral keratinocyte pathophysiology
口腔角质形成细胞病理生理学中的细胞周期蛋白 D1 和维生素 D 信号传导
基本信息
- 批准号:8743203
- 负责人:
- 金额:$ 11.55万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-09-26 至 2016-08-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAndrogen ReceptorBindingBiochemical PathwayBiological ModelsBody partCDK4 geneCancer SurvivorCell CycleCell Cycle ProgressionCell Cycle RegulationCell Differentiation processCell ProliferationChemicalsChemopreventive AgentChronicCyclin D1Cyclin-Dependent KinasesDataDefectDermalDevelopmentDietDiseaseDysplasiaEpithelial CellsEpitheliumEsophagusEstheticsEstrogen ReceptorsEventFunctional disorderGene ExpressionGene TargetingGenesGoalsHumanIntraepithelial NeoplasiaKnowledgeLesionMalignant - descriptorMalignant NeoplasmsMediatingMediator of activation proteinMedicalModelingMolecularMolecular GeneticsMorbidity - disease rateMusNeoplasmsNeoplastic ProcessesNuclear Hormone ReceptorsNutritionalNutritional statusOncogenesOncogenicOperative Surgical ProceduresOralOral cavityOropharyngeal Squamous Cell CarcinomaPathway interactionsPhenotypePhosphorylationPhosphotransferasesPhysiologyPlayPremalignantProcessPromoter RegionsPublic HealthQuality of lifeRXRRadiation therapyRegulationRetinoblastoma ProteinRiskRoleS PhaseSTAT3 geneSignal PathwaySignal TransductionSiteSupplementationSurvival RateTestingTherapeuticTongueTranscriptional RegulationTransgenic MiceUnited StatesVitamin DVitamin D DeficiencyVitamin D3 ReceptorVitaminscancer riskcancer typeimmunoregulationimprovedkeratinocytekeratinocyte differentiationmalignant mouth neoplasmmalignant oropharynx neoplasmmortalitymouse modelneoplasticnoveloral carcinogenesisoral dysplasiaoral premalignancyoverexpressionpharynx squamous cell carcinomapublic health relevancereceptor functiontranscription factortumortumorigenesis
项目摘要
DESCRIPTION (provided by applicant): The focus of this proposal is on the role of the cyclin D1 oncogene in oral cancer. Oropharyngeal squamous cell carcinomas (OSCC) are aggressive tumors that result in significant mortality and morbidity. Frequently, these tumors initiate as a precancerous lesion that develops to an invasive neoplasm. However, the molecular mechanisms underlying the transition to invasive neoplasia are not fully understood. Furthermore, the role of dietary agents in modifying this process has not been studied. The cyclin D1 oncogene plays an important role in OSCC development. Cyclin D1 is a key regulator of the G1-S phase of the cell cycle. Acting via its kinase partners CDK4 and CDK6, it results in phosphorylation of the retinoblastoma protein to effect cell cycle progression. The current paradigm assumes that this is the major mechanism of cyclin D1's oncogenic actions. However, there is emerging evidence that cyclin D1 participates in transcriptional control. We recently discovered that cyclin D1 binds to the vitamin D receptor (VDR) and modulates vitamin D signaling. This finding is particularly significant in that vitamin D plays an essential role in regulation of keratinocyte proliferation and differentiation. The studies described in this proposa will study the intersection between the cyclin D1 and vitamin D signaling pathways. The short-term goals of this proposal are to (1) examine the mechanism by which cyclin D1 deregulates vitamin D signaling and (2) examine role of dietary vitamin D deficiency in modulating the development of oral pre-cancer and cancer. The long-term goal is to study the contribution of vitamin D signaling in oral keratinocyte physiology and pathophysiology, its intersection with oncogenic pathways and its implications for oral carcinogenesis. To achieve these goals two Specific Aims are proposed. Specific Aim 1 will investigate the mechanism by which cyclin D1 deregulates VDR-mediated transcriptional control. Specific Aim 2 will examine the role of dietary vitamin D deficiency in modulating cyclin D1-driven oral pre-cancer using a transgenic mouse model system. These studies will significantly increase our understanding of cyclin D1's oncogenic mechanisms and vitamin D's role in modulating oral cancer risk. Given the emerging problem of vitamin D nutritional status both in the United States as well as globally, our studies have tremendous implications for potential dietary and chemopreventive approaches to oral cancer management. Furthermore, cyclin D1 is an established oncogene for several tumor types and there is growing evidence for vitamin D's role in several cancers. Thus, our studies have potentially broad implications for several other tumors types.
描述(由申请人提供):本提案的重点是细胞周期蛋白D1癌基因在口腔癌中的作用。口咽部鳞状细胞癌(OSCC)是一种侵袭性肿瘤,导致显著的死亡率和发病率。通常,这些肿瘤起始于癌前病变,发展为侵袭性肿瘤。然而,向侵袭性肿瘤转变的分子机制还不完全清楚。此外,还没有研究过饮食制剂在改变这一过程中的作用。cyclin D1癌基因在口腔鳞癌的发生发展中起重要作用。细胞周期蛋白D1是细胞周期G1-S期的关键调节因子。通过其激酶伴侣CDK 4和CDK 6起作用,导致视网膜母细胞瘤蛋白磷酸化以影响细胞周期进程。目前的范式假设这是细胞周期蛋白D1的致癌作用的主要机制。然而,有新的证据表明,细胞周期蛋白D1参与转录控制。我们最近发现,细胞周期蛋白D1结合维生素D受体(VDR)和调节维生素D信号。这一发现特别重要,因为维生素D在调节角质形成细胞增殖和分化中起重要作用。本提案中描述的研究将研究细胞周期蛋白D1和维生素D信号通路之间的交叉。该提案的短期目标是(1)检查细胞周期蛋白D1失调维生素D信号传导的机制和(2)检查饮食维生素D缺乏在调节口腔癌前病变和癌症发展中的作用。长期目标是研究维生素D信号在口腔角质形成细胞生理学和病理生理学中的作用,其与致癌途径的交叉及其对口腔癌发生的影响。为了实现这些目标,提出了两个具体目标。具体目标1将调查的机制,细胞周期蛋白D1失调VDR介导的转录控制。具体目标2将检查饮食中的维生素D缺乏的作用,在调制细胞周期蛋白D1驱动的口腔癌前病变使用转基因小鼠模型系统。这些研究将显著增加我们对细胞周期蛋白D1的致癌机制和维生素D在调节口腔癌风险中的作用的理解。鉴于美国和全球维生素D营养状况的新问题,我们的研究对口腔癌管理的潜在饮食和化学预防方法具有巨大的影响。此外,细胞周期蛋白D1是几种肿瘤类型的既定致癌基因,越来越多的证据表明维生素D在几种癌症中的作用。因此,我们的研究对其他几种肿瘤类型具有潜在的广泛意义。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Vitamin D signaling regulates oral keratinocyte proliferation in vitro and in vivo.
- DOI:10.3892/ijo.2014.2338
- 发表时间:2014-05
- 期刊:
- 影响因子:5.2
- 作者:Yuan FN;Valiyaparambil J;Woods MC;Tran H;Pant R;Adams JS;Mallya SM
- 通讯作者:Mallya SM
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SANJAY M MALLYA其他文献
SANJAY M MALLYA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SANJAY M MALLYA', 18)}}的其他基金
Cyclin D1 and vitamin D signaling in oral keratinocyte pathophysiology
口腔角质形成细胞病理生理学中的细胞周期蛋白 D1 和维生素 D 信号传导
- 批准号:
8444229 - 财政年份:2013
- 资助金额:
$ 11.55万 - 项目类别:
Effects of PTH Excess on Cortical and Cancellous Bone
PTH 过量对皮质骨和松质骨的影响
- 批准号:
6857503 - 财政年份:2005
- 资助金额:
$ 11.55万 - 项目类别:
Effects of PTH Excess on Cortical and Cancellous Bone
PTH 过量对皮质骨和松质骨的影响
- 批准号:
7015040 - 财政年份:2005
- 资助金额:
$ 11.55万 - 项目类别:
相似海外基金
Androgen receptor: A master regulator of lipid metabolism
雄激素受体:脂质代谢的主要调节因子
- 批准号:
DP230103210 - 财政年份:2023
- 资助金额:
$ 11.55万 - 项目类别:
Discovery Projects
Regulation of androgen receptor signaling in prostate cancer by protein arginine methylation
通过蛋白质精氨酸甲基化调节前列腺癌中的雄激素受体信号传导
- 批准号:
10584689 - 财政年份:2023
- 资助金额:
$ 11.55万 - 项目类别:
Structural and functional analysis of a novel class of androgen receptor antagonists
一类新型雄激素受体拮抗剂的结构和功能分析
- 批准号:
10650956 - 财政年份:2023
- 资助金额:
$ 11.55万 - 项目类别:
Role of the Androgen Receptor in Insulin Secretion in the Male
雄激素受体在男性胰岛素分泌中的作用
- 批准号:
10488954 - 财政年份:2023
- 资助金额:
$ 11.55万 - 项目类别:
Targeting tumor cell macrophage lipid interactions to overcome resistance to androgen receptor targeted therapy
靶向肿瘤细胞巨噬细胞脂质相互作用以克服对雄激素受体靶向治疗的耐药性
- 批准号:
10651105 - 财政年份:2023
- 资助金额:
$ 11.55万 - 项目类别:
Preclinical development of ONCT-505, an Androgen Receptor Antagonist and Degrader, as new potential therapeutic for Kennedy's Disease
ONCT-505(一种雄激素受体拮抗剂和降解剂)的临床前开发,作为肯尼迪病的新潜在治疗方法
- 批准号:
10603636 - 财政年份:2023
- 资助金额:
$ 11.55万 - 项目类别:
Proliferating cell nuclear antigen in regulation of androgen receptor signalings in castration-resistant prostate cancer cells
增殖细胞核抗原对去势抵抗性前列腺癌细胞雄激素受体信号传导的调节
- 批准号:
10544062 - 财政年份:2022
- 资助金额:
$ 11.55万 - 项目类别:
Effects of androgen receptor (AR) signaling on CD4+ T cell metabolism during airway inflammation
气道炎症期间雄激素受体 (AR) 信号对 CD4 T 细胞代谢的影响
- 批准号:
10534943 - 财政年份:2022
- 资助金额:
$ 11.55万 - 项目类别:
TITLE: BLADDER CANCER CHEMOPREVENTION USING THE ANDROGEN RECEPTOR INHIBITOR APALUTAMIDE
标题:使用雄激素受体抑制剂阿帕鲁胺进行膀胱癌化学预防
- 批准号:
10677989 - 财政年份:2022
- 资助金额:
$ 11.55万 - 项目类别: